Interim Analysis: Open-label Extension Study of Leniolisib for Patients with APDS.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY(2024)
关键词
APDS,primary immunodeficiency,PI3Kd inhibitor,clinical trial,long-term safety,B cells,T cells,lymphoproliferation,PIK3CD
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要